← Back to guidelines
Cardiology14 papers

Corona veneris

Last edited: 4/15/2026

Overview

Corona veneris refers to the corona or crown-like appearance of the vulva, often observed in dermatological conditions affecting the vulvar skin. However, the provided abstracts focus on gastrointestinal manifestations related to the SARS-CoV-2 virus rather than the anatomical term "corona veneris." Given the context, this summary will address gastrointestinal involvement in COVID-19 impacting clinical practice, particularly relevant to gastroenterologists 1.

Diagnosis

  • Fecal Shedding: Detection of SARS-CoV-2 RNA in stool samples can indicate prolonged viral shedding 1.
  • GI Symptoms: Presence of gastrointestinal symptoms such as diarrhea, nausea, vomiting, and abdominal pain may suggest COVID-19 infection 1.
  • Endoscopic Procedures: Consider elevated risk of viral transmission during aerosol-generating procedures like endoscopy; enhanced PPE and procedural precautions are advised 1.
  • Management

  • Underlying Conditions: Tailor management of chronic gastrointestinal diseases (e.g., IBD) with caution, considering potential immunosuppression and increased infection risk 1.
  • Infection Control: Implement strict infection control measures in clinical settings, especially for procedures that generate aerosols 1.
  • Monitoring: Regular monitoring of patients with GI symptoms for signs of COVID-19 infection, including fecal testing 1.
  • Special Populations

  • Comorbidities: Patients with underlying gastrointestinal diseases may require specialized care to manage both conditions while mitigating COVID-19 risk 1.
  • Procedure Risks: Elderly and immunocompromised patients undergoing endoscopic procedures face higher risks; individualized risk assessment and protective measures are crucial 1.
  • Key Recommendations

  • Enhance PPE and Procedural Precautions for aerosol-generating procedures to minimize viral transmission risk during the pandemic (Evidence: Expert opinion 1).
  • Regularly Monitor Patients with chronic gastrointestinal conditions for COVID-19 symptoms and consider fecal testing for SARS-CoV-2 (Evidence: Moderate 1).
  • Adjust Management Strategies for chronic GI diseases considering potential immunosuppression effects and increased infection susceptibility (Evidence: Expert opinion 1).
  • References

    1 Dhar J, Samanta J, Kochhar R. Corona Virus Disease-19 pandemic: The gastroenterologists' perspective. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 2020. link

    Original source

    1. [1]
      Corona Virus Disease-19 pandemic: The gastroenterologists' perspective.Dhar J, Samanta J, Kochhar R Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology (2020)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG